Neuroprotection in mice by NGP1-01 after transient focal brain ischemia

Brain Research

Volumn 1196, Issue , 2008, Pages 113-120

  Hao, Jiukuan ^a   Mdzinarishvili, Alexander ^a   Abbruscato, Thomas J ^a   Klein, Jochen ^b   Geldenhuys, Werner J ^c   Van der Schyf, Cornelis J ^c   Bickel, Ulrich ^a  

^a Texas Tech School of Pharmacy   (United States)

^b GOETHE UNIVERSITY   (Germany)

^c NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

NMDA receptor; Stroke; Transient focal ischemia; Voltage gated calcium channel

Indexed keywords

MEMANTINE; NEUROPROTECTIVE AGENT; NGP 101; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CONTROLLED STUDY; FEMALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN INFARCTION; BRAIN ISCHEMIA; BRIDGED COMPOUNDS; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; FEMALE; MICE; NEUROPROTECTIVE AGENTS; ORGANIC CHEMICALS; PERCEPTUAL DISORDERS; PHOSPHOPYRUVATE HYDRATASE; TIME FACTORS;

ANIMALIA; MUS; RODENTIA;

EID: 39149141841     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2007.11.075     Document Type: Article

References (28)

1. Bardutzky J., Meng X., Bouley J., Duong T.Q., Ratan R., and Fisher M. Effects of intravenous dimethyl sulfoxide on ischemia evolution in a rat permanent occlusion model. J. Cereb. Blood Flow Metab. 25 (2005) 968-977
2. Benedek A., Moricz K., Juranyi Z., Gigler G., Levay G., Harsing Jr. L.G., Matyus P., Szenasi G., and Albert M. Use of TTC staining for the evaluation of tissue injury in the early phases of reperfusion after focal cerebral ischemia in rats. Brain Res. 1116 (2006) 159-165
3. Bouet V., Freret T., Toutain J., Divoux D., Boulouard M., and Schumann-Bard P. Sensorimotor and cognitive deficits after transient middle cerebral artery occlusion in the mouse. Exp. Neurol. 203 (2007) 555-567
4. Duckworth E.A., Butler T., Collier L., Collier S., and Pennypacker K.R. NF-kappaB protects neurons from ischemic injury after middle cerebral artery occlusion in mice. Brain Res. 1088 (2006) 167-175
5. Duckworth E.A., Butler T.L., De Mesquita D., Collier S.N., Collier L., and Pennypacker K.R. Temporary focal ischemia in the mouse: technical aspects and patterns of Fluoro-Jade evident neurodegeneration. Brain Res. 1042 (2005) 29-36
6. Geldenhuys W.J., Malan S.F., Bloomquist J.R., Marchand A.P., and Van der Schyf C.J. Pharmacology and structure-activity relationships of bioactive polycyclic cage compounds: a focus on pentacycloundecane derivatives. Med. Res. Rev. 25 (2005) 21-48
7. Geldenhuys W.J., Malan S.F., Murugesan T., Van der Schyf C.J., and Bloomquist J.R. Synthesis and biological evaluation of pentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecane derivatives as potential therapeutic agents in Parkinson's disease. Bioorg. Med. Chem. 12 (2004) 1799-1806
8. Geldenhuys W.J., Terre'Blanche G., Van der Schyf C.J., and Malan S.F. Screening of novel pentacyclo-undecylamines for neuroprotective activity. Eur. J. Pharmacol. 458 (2003) 73-79
9. Hesselink M.B., De Boer B.G., Breimer D.D., and Danysz W. Brain penetration and in vivo recovery of NMDA receptor antagonists amantadine and memantine: a quantitative microdialysis study. Pharm. Res. 16 (1999) 637-642
10. Kaye T.S., Egorin M.J., Riggs Jr. C.E., Olman E.A., Chou F.T., and Salcman M. The plasma pharmacokinetics and tissue distribution of dimethyl sulfoxide in mice. Life Sci. 33 (1983) 1223-1230
11. Kiewert C., Hartmann J., Stoll J., Thekkumkara T.J., Van der Schyf C.J., and Klein J. NGP1-01 is a brain-permeable dual blocker of neuronal voltage- and ligand-operated calcium channels. Neurochem. Res. 31 (2006) 395-399
12. Li X., Blizzard K.K., Zeng Z., DeVries A.C., Hurn P.D., and McCullough L.D. Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender. Exp. Neurol. 187 (2004) 94-104
13. Mdzinarishvili A., Geldenhuys W.J., Abbruscato T.J., Bickel U., Klein J., and Van der Schyf C.J. NGP1-01, a lipophilic polycyclic cage amine, is neuroprotective in focal ischemia. Neurosci. Lett. 383 (2005) 49-53
14. Morphy R., and Rankovic Z. Designed multiple ligands. An emerging drug discovery paradigm. J. Med. Chem. 48 (2005) 6523-6543
15. Nagel S., Genius J., Heiland S., Horstmann S., Gardner H., and Wagner S. Diphenyleneiodonium and dimethylsulfoxide for treatment of reperfusion injury in cerebral ischemia of the rat. Brain Res. 1132 (2007) 210-217
16. Parsons C.G., Danysz W., and Quack G. Memantine is a clinically well tolerated N-methyl-d-aspartate (NMDA) receptor antagonist-a review of preclinical data. Neuropharmacology 38 (1999) 735-767
17. Rod M.R., and Auer R.N. Combination therapy with nimodipine and dizocilpine in a rat model of transient forebrain ischemia. Stroke 23 (1992) 725-732
18. Savitz S.I., and Fisher M. Future of neuroprotection for acute stroke: in the aftermath of the SAINT trials. Ann. Neurol. 61 (2007) 396-402
19. Schmued L.C., and Hopkins K.J. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 874 (2000) 123-130
20. Shen F., Su H., Fan Y., Chen Y., Zhu Y., Liu W., Young W.L., and Yang G.Y. Adeno-associated viral-vector-mediated hypoxia-inducible vascular endothelial growth factor gene expression attenuates ischemic brain injury after focal cerebral ischemia in mice. Stroke 37 (2006) 2601-2606
21. Sorant P.E., and Shenkel J.R. The calculation of volumes of middens, mounts, and strata having irregular shapes. Am. Antiq. 49 (1984) 599-603
22. Stieg P.E., Sathi S., Warach S., Le D.A., and Lipton S.A. Neuroprotection by the NMDA receptor-associated open-channel blocker memantine in a photothrombotic model of cerebral focal ischemia in neonatal rat. Eur. J. Pharmacol. 375 (1999) 115-120
23. Stuiver B.T., Douma B.R., Bakker R., Nyakas C., and Luiten P.G. In vivo protection against NMDA-induced neurodegeneration by MK-801 and nimodipine: combined therapy and temporal course of protection. Neurodegeneration 5 (1996) 153-159
24. Uematsu D., Araki N., Greenberg J.H., Sladky J., and Reivich M. Combined therapy with MK-801 and nimodipine for protection of ischemic brain damage. Neurology 41 (1991) 88-94
25. Van der Schyf C.J., Gal S., Geldenhuys W.J., and Youdim M.B. Multifunctional neuroprotective drugs targeting monoamine oxidase inhibition, iron chelation, adenosine receptors, and cholinergic and glutamatergic action for neurodegenerative diseases. Expert. Opin. Investig. Drugs 15 (2006) 873-886
26. Van der Schyf C.J., Geldenhuys W.J., and Youdim M.B. Multifunctional drugs with different CNS targets for neuropsychiatric disorders. J. Neurochem. 99 (2006) 1033-1048
27. Van der Schyf C.J., Squier G.J., and Coetzee W.A. Characterization of NGP 1-01, an aromatic polycyclic amine, as a calcium antagonist. Pharmacol. Res. Commun. 18 (1986) 407-417
28. Zhang L., Schallert T., Zhang Z.G., Jiang Q., Arniego P., Li Q., Lu M., and Chopp M. A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia. J. Neurosci. Methods 117 (2002) 207-214